financing

News

Welsh firm Antiverse raises funds for AI antibody platform

Cardiff's Antiverse has raised $9.3m to develop its AI-based design platform for antibodies against hard-to-reach targets like GPCRs and ion channels.

News

Doctor listens through a stethoscope to a boy's breathing

ILiAD bags $115m for pertussis vaccine, and other financings

This week's biofinancings include a nine-figure round for ILiAD, with Quantx Bio, Aerska, Galux, and Pandorum Technologies also raising new funds.

News

Euro VCs team up to invigorate life sciences ecosystem

Major venture capital groups in Europe have joined forces to set up a new coalition aimed at revitalising access to life sciences investment.

News

Eikon, Veradermics close IPOs, as Salspera joins queue

Eikon and Veradermics push upsized IPOs over the line, as Salspera, which is developing live microbial immunotherapies for cancer, seeks a listing.

News

Three more biotechs price their Nasdaq IPOs

AgomAb, SpyGlass, and Veradermics have all set the terms for their IPOs this week, looking to raise somewhere between around $150m and $200m.

News

Eikon prices its IPO, seeking to raise $318m

Roger Perlmutter's new cancer biotech Eikon has priced its IPO, looking to raise up to $318m and achieve a $900m-plus valuation.

Welsh firm Antiverse raises funds for AI antibody platform

ILiAD bags $115m for pertussis vaccine, and other financings

Euro VCs team up to invigorate life sciences ecosystem

Eikon, Veradermics close IPOs, as Salspera joins queue

Three more biotechs price their Nasdaq IPOs

Eikon prices its IPO, seeking to raise $318m

FDA approves leucovorin – but not for autism

Using AI-driven synthetic personas to take your insights fur...

financing

Editor's Picks